Clinical trials
Phase 1 Schizophrenia trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| Autifony Therapeutics Limited | 4 |
| King's College London | 3 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| H. Lundbeck A/S | 1 |
| Hoffmann-La Roche | 1 |
| Minerva Neurosciences | 1 |
| Neurocrine Biosciences | 1 |
| Takeda | 1 |
| Teva Branded Pharmaceutical Products R&D LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 23 |
| Cognitive Dysfunction | 2 |
| Alzheimer Disease | 1 |
| Cerebellar Ataxia | 1 |
| Mental Disorders | 1 |
| Psychotic Disorders | 1 |
| Schizophrenia, Treatment-Resistant | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.